You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 141 No. 3, March 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

VIGNETTES
Drug-Induced Eosinophilia and Systemic Symptoms: Hypersensitivity or Peripheral T-Cell Lymphoma?

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

A 44-year old woman was admitted for a maculopapular rash with pruritus, facial edema, and fever 6 weeks after beginning treatment with diclofenac for lombalgias. On physical examination she had enlarged cervical and inguinofemoral lymph nodes, hepatomegaly, and a diffuse crackling noise on chest auscultation. She had a white blood cell count of 45 x 103/µL with 38% eosinophils and mononucleosislike lymphocytes; normal platelet count; normal hemoglobin concentration with total IgE concentration of 1070 UI/L (normal concentration <100 UI/L); polyclonal gammopathy; elevated creatinine levels (1.56 mg/dL [138 µmol/L]); and no antinuclear antibodies or rheumatoid factors. Extensive serologic studies and cultures showed no bacterial, viral, or fungal infection. A chest radiograph showed a bilateral basal interstitial lung infiltrate. The patient’s status worsened rapidly as the diffuse maculopapular rash coalesced into an extensive erythematous (in places violaceous) eruption (Figure), and she experienced respiratory distress that required artificial ventilation. Histologic . . . [Full Text of this Article]


AUTHOR INFORMATION
Nicolas Schleinitz, MD; Véronique Veit, MD; Diane Coso, MD; Thérèse Aurran, MD; Phillippe Berbis, MD; Jean-Robert Harle, MD


RELATED ARTICLES

Long-term Follow-up of Patients With Early-Stage Cutaneous T-Cell Lymphoma Who Achieved Complete Remission With Psoralen Plus UV-A Monotherapy
Christiane Querfeld, Steven T. Rosen, Timothy M. Kuzel, Katharine A. Kirby, Henry H. Roenigk, Jr, Bettina M. Prinz, and Joan Guitart
Arch Dermatol. 2005;141(3):305-311.
ABSTRACT | FULL TEXT  

Health-Related Quality-of-Life Assessment in Patients With Cutaneous T-Cell Lymphoma
Marie-France Demierre, Amy Tien, and Donald Miller
Arch Dermatol. 2005;141(3):325-330.
ABSTRACT | FULL TEXT  

Mycosis Fungoides–Type Cutaneous T-Cell Lymphoma and Neutrophilic Dermatosis
Nathalie Franck, Agnes Carlotti, Isabelle Gorin, Marc Buffet, Christine Mateus, Nicolas Dupin, and for the French Study Group on Cutaneous Lymphomas
Arch Dermatol. 2005;141(3):353-356.
ABSTRACT | FULL TEXT  

Monoclonal T-Cell Dyscrasia of Undetermined Significance Associated With Recalcitrant Erythroderma
Robert Gniadecki and Ansgar Lukowsky
Arch Dermatol. 2005;141(3):361-367.
ABSTRACT | FULL TEXT  

Dyscrasias With "Undetermined Significance"
Günter Burg, Reinhard Dummer, and Werner Kempf
Arch Dermatol. 2005;141(3):382-384.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.